Iron administration during erythropoietin therapy in hemodialysis patients
Fourtounas, C.; Kavadias, D.; Tsouchnikas, J.; Barboutis, K.
International Journal of Artificial Organs 17(12): 670
1994
ISSN/ISBN: 0391-3988 PMID: 7759148 Document Number: 437743
Document emailed within 1 workday
Related Documents
Nurnuansuwan, S.; Leelahavanichkul, A.; Pansin, P.; Eiam-Ong, S. 2005: Intravenous iron administration during the maintenance period in erythropoietin-treated hemodialysis patients: a simple and effective method Journal of the Medical Association of Thailand 88(Suppl 4): S184-S188Kao, H.H.; Chen, K.S.; Tsai, C.J.; Lee, C.C.; Chang, H.Y. 2000: Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy Chang Gung Medical Journal 23(10): 608-613
Agroyannis, B.; Koutsicos, D.; Tzanatou-Exarchou, H.; Varsou-Papadimitriou, E.; Kapetanaki, A.; Yatzidis, H. 1991: Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients International Journal of Artificial Organs 14(7): 403-406
Hsu, P-Yaur.; Lin, C-Liang.; Yu, C-Chen.; Chien, C-Chun.; Hsiau, T-Gu.; Sun, T-Hui.; Huang, L-Mei.; Yang, C-Wei. 2004: Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study Journal of Nephrology 17(5): 693-700
Tsai, J.C.; Lai, Y.H.; Tsai, Z.Y.; Chien, L.J.; Tsai, J.H. 1991: Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum Gaoxiong Yi Xue Ke Xue Za Zhi 7(3): 126-135
Kurihara, I.; Saito, T. 2002: Significance of parenteral iron administration for HCV-positive hemodialysis patients Nihon Jinzo Gakkai Shi 44(4): 389-395
Kes, P.; Bobić, I.; Reiner, Z.; Ratković-Gusić, I. 2002: Effect of erythropoietin therapy on serum lipoprotein levels in patients on hemodialysis Lijecnicki Vjesnik 124(5): 146-150
Riedel, E.; Hampl, H.; Scigalla, P.; Nündel, M.; Kessel, M. 1989: Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients Kidney International. Supplement 27: S216-S221
Ohkubo, M.; Ishimitsu, T.; Kawaguchi, T.; Abe, M.; Yagi, S. 1993: Efficacy and safety of long-term erythropoietin therapy in chronic hemodialysis patients with renal anemia Nihon Jinzo Gakkai Shi 35(2): 171-177
Bergmann, M.; Grützmacher, P.; Heuser, J.; Kaltwasser, J.P. 1990: Iron metabolism under rEPO therapy in patients on maintenance hemodialysis International Journal of Artificial Organs 13(2): 109-112
Takayama, K. 1993: Changes in endothelial vasoactive substances and blood coagulation and fibrinolysis functions under recombinant human erythropoietin therapy in hemodialysis patients Nihon Jinzo Gakkai Shi 35(2): 179-188
Laupacis, A. 1991: A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group Transplantation Proceedings 23(2): 1825-1826
Hou, C.C.; Wu, S.C.; Wu, S.C.; Chen, T.W.; Yang, W.C.; Ng, Y.Y. 1999: Is serum transferrin receptor a sensitive marker of iron repletion in patients with iron-deficiency anemia and hemodialysis patients? Zhonghua Yi Xue Za Zhi 62(4): 189-194
Satirapoj, B.; Supasyndh, O.; Choovichian, P. 2014: A comparative study of efficacy and safety of the lyophilized powder alpha-erythropoietin and the liquid form alpha-erythropoietin for hemoglobin maintenance in patients with hemodialysis treatment Journal of the Medical Association of Thailand 97(9): 899-906
Kumar, P. 1999: Erythropoietin and iron therapy for preterm infants Journal of Pediatrics 134(4): 520-522
Icardi, A.; Paoletti, E.; Traverso, G.B.; Sarchi, C.; Cappelli, G.; Molinelli, G. 1991: Red cell membrane during erythropoietin therapy in hemodialysis and in hemodiafiltration International Journal of Artificial Organs 14(3): 147-149
Rozental', R.L.; Zezina, L.Iu.; Spudass, A.V. 1991: The use of recombinant erythropoietin with patients on programmed hemodialysis Terapevticheskii Arkhiv 63(12): 110-113
Hotta, T.; Ogawa, H.; Saito, A.; Ito, A. 1991: Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure International Journal of Hematology 54(3): 195-200
Zehnder, C.; Blumberg, A. 1988: Cerebrovascular incidents in 4 hemodialysis patients treated with erythropoietin Schweizerische Medizinische Wochenschrift 118(40): 1423-1426
Jacquot, C.; Berthelot, J.M.; Chiappini-Judith, D.; Ferragu-Haguet, M.; Lefebvre, A.; Masselot, J.P.; Moynot, A.; Frydman, M.O.; Peterlongo, F. 1990: Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients Nephrologie 11(1): 11-16